Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated 40 minutes ago
FDA warning slams Zoll Medical with multiple quality control and reporting violations
40 minutes ago
Zoll Medical, the maker of devices and software focused on cardiopulmonary and...
How data-driven diagnostic lab services drive precise clinical trial enrollment
about 16 hours ago
Drug commercialization depends on reaching the right physicians at the right moment.
Moderna’s flu candidate sails through FDA advisory committee in unanimous votes
about 18 hours ago
As Moderna reshapes itself in the wake of the pandemic, the company...
cAMPfield harvests $180M series A to advance oral IBD drug licensed from Newsoara
about 23 hours ago
In another biotech born out of China’s “NewCo” model, cAMPfield Therapeutics has...
Novocure device fails to improve brain cancer patients’ survival in phase 3 test
1 day ago
Novocure’s tumor-treating electric fields device missed its primary endpoint in a late-stage...
Kardigan buttons up $400M upsized IPO to power heart drugs toward phase 3
1 day ago
Kardigan’s IPO haul has come in 14% above expectations, grossing $400 million...
Nortiva purrs into action with long-acting Lynx platform salvaged from Langer startup
1 day ago
Innoviva has revealed the next steps for Langer Lab assets it rescued...
Biogen inks $1B RayThera buyout to bag preclinical immunology assets
1 day ago
Biogen has struck a backloaded, $1 billion deal to buy RayThera, snagging...
F2G, Shionogi prep regulatory push after novel antifungal passes ph. 3 test
1 day ago
F2G and Shionogi have released phase 3 data for the oral antifungal...
‘We think about it every day’: How Daiichi Sankyo’s R&D chief plans to stay ahead in the ADC game
1 day ago
John Tsai, M.D., is rounding out his global drug development resume. Immediately...
FDA Breakthrough Therapy and RMAT: Strategic Decisions That Can Accelerate Oncology Development
2 days ago
Explore how FDA Breakthrough Therapy and RMAT designations can create opportunities for...
For biopharma manufacturing at speed and scale, the future is flexible
2 days ago
Biopharma development has long trended toward specialized and personalized therapies such as...